<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">63035</id>
  <title nil="true"/>
  <common-name>N,N-Dimethyl-3-[(1-oxooctadecyl)amino]-N-[2-oxo-2-(tetradecyloxy)ethyl]-1-propanaminium</common-name>
  <description>N,N-Dimethyl-3-[(1-oxooctadecyl)amino]-N-[2-oxo-2-(tetradecyloxy)ethyl]-1-propanaminium belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. It has the chemical formula C39H79N2O3. With an average molecular weight of 624.10 g/mol, N,N-Dimethyl-3-[(1-oxooctadecyl)amino]-N-[2-oxo-2-(tetradecyloxy)ethyl]-1-propanaminium is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>111773</pubchem-id>
  <chemical-formula>C39H79N2O3</chemical-formula>
  <weight>624.1</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-02T23:01:22Z</created-at>
  <updated-at type="dateTime">2026-08-31T23:22:33Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCCCC</moldb-smiles>
  <moldb-formula>C39H79N2O3</moldb-formula>
  <moldb-inchi>InChI=1S/C39H78N2O3.ClH/c1-5-7-9-11-13-15-17-19-20-21-22-24-26-28-30-33-38(42)40-34-32-35-41(3,4)37-39(43)44-36-31-29-27-25-23-18-16-14-12-10-8-6-2;/h5-37H2,1-4H3;1H</moldb-inchi>
  <moldb-inchikey>CARJGAHURMGKDU-UHFFFAOYSA-O</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">623.609069</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>14.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>100233</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM058928</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00014031</susdat-id>
  <iupac>Dimethyl-[3-(octadecanoylamino)propyl]-(2-oxo-2-tetradecoxyethyl)azanium</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0099645</sync-id>
  <structure-inchikey>CARJGAHURMGKDU-UHFFFAOYSA-O</structure-inchikey>
  <structure-fingerprint>40000024000000000800000000000200010000000000004000000000000000000000002000000000000000000000000000002000000000000000000000000000000000000000000010400000008080020001000000100000000000000000000000020010000010000000001000000000040000000000000000000000000000020000040000000000000000000010080000000000000000000000040001000000000000000000000000000002000200000000008000000000000000000000000000008000004000000000000000000000000000000020002000000001000000000000000000000000008000000010400000000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAAKwAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:16:00Z</structure-indexed-at>
</compound>
